Category: Y90

If you diagnose or treat patients with liver cancer, then you’re probably familiar with the procedure for Yttrium-90 (Y90) studies. In short, the patient must go through a mapping process to ensure that the medical team gets the best possible information from which to treat them. This involves examining the

Radioembolization with Y90 is a minimally invasive procedure primarily used in the treatment of liver cancer. In contrast to most nuclear medicine applications, Y90 is therapeutic and designed to treat rather than simply diagnose. It is estimated that 75% to 95% of patients see improvement from treatment, potentially extending their